Jones H, Cooper P, Miller V, Brooks N, Whorwell P J
Department of Medicine, Wythenshawe Hospital, Manchester, UK.
Gut. 2006 Oct;55(10):1403-8. doi: 10.1136/gut.2005.086694. Epub 2006 Apr 20.
Non-cardiac chest pain (NCCP) is an extremely debilitating condition of uncertain origin which is difficult to treat and consequently has a high psychological morbidity. Hypnotherapy has been shown to be effective in related conditions such as irritable bowel syndrome where its beneficial effects are long lasting.
This study aimed to assess the efficacy of hypnotherapy in a selected group of patients with angina-like chest pain in whom coronary angiography was normal and oesophageal reflux was not contributory.
Twenty eight patients fulfilling the entry criteria were randomised to receive, after a four week baseline period, either 12 sessions of hypnotherapy or supportive therapy plus placebo medication over a 17 week period. The primary outcome measure was global assessment of chest pain improvement. Secondary variables were a change in scores for quality of life, pain severity, pain frequency, anxiety, and depression, as well as any alteration in the use of medication.
Twelve of 15 (80%) hypnotherapy patients compared with three of 13 (23%) controls experienced a global improvement in pain (p = 0.008) which was associated with a significantly greater reduction in pain intensity (p = 0.046) although not frequency. Hypnotherapy also resulted in a significantly greater improvement in overall well being in addition to a reduction in medication usage. There were no differences favouring hypnotherapy with respect to anxiety or depression scores.
Hypnotherapy appears to have use in this highly selected group of NCCP patients and warrants further assessment in the broader context of this disorder.
非心源性胸痛(NCCP)是一种极为使人衰弱的疾病,病因不明,难以治疗,因此心理发病率很高。催眠疗法已被证明在相关病症如肠易激综合征中有效,其有益效果持久。
本研究旨在评估催眠疗法对一组经冠状动脉造影正常且无食管反流因素的心绞痛样胸痛患者的疗效。
28名符合入选标准的患者在经过4周的基线期后,被随机分配在17周内接受12次催眠疗法或支持性疗法加安慰剂药物治疗。主要结局指标是对胸痛改善情况的整体评估。次要变量包括生活质量、疼痛严重程度、疼痛频率、焦虑和抑郁评分的变化,以及药物使用的任何改变。
15名接受催眠疗法的患者中有12名(80%)与13名对照组患者中的3名(23%)相比,疼痛有整体改善(p = 0.008),这与疼痛强度显著降低相关(p = 0.046),尽管疼痛频率未降低。催眠疗法除了减少药物使用外,还使整体幸福感有显著更大的改善。在焦虑或抑郁评分方面,没有有利于催眠疗法的差异。
催眠疗法似乎对这一高度选择的NCCP患者群体有用,值得在该疾病的更广泛背景下进一步评估。